Jasper Therapeutics- Warrants (24/09/2026) Total Current Liabilities

As of the most recent data (March 2026), JSPRW shows a total current liabilities of $9M. That compares with $12M in the prior-year period — down 27.1% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, JSPRW's total current liabilities is now $9M (was $12M) — a 27.1% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Jasper Therapeutics- Warrants (24/09/2026) is outperforming or lagging.

Tracking JSPRW's total current liabilities over time shows whether Jasper Therapeutics- Warrants (24/09/2026) is scaling, shrinking, or reshaping that part of the business. The current reading is $9M That compares with $12M in the prior-year period — down 27.1% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total current liabilities page, Stockcircle has Jasper Therapeutics- Warrants (24/09/2026)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total current liabilities (currently $9M) with ownership activity and broader fundamentals.